#	Pagina
attuale pagina	/open-h2020/projects/216845/index.html

Opendata, web and dolomites

DiaMOND SIGNED

personalised Diabetes Management using lOw-cost Needle-free multiple-biomarkers monitoring Device

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

DiaMOND project word cloud

Explore the words cloud of the DiaMOND project. It provides you a very rough idea of what is the project "DiaMOND" about.

ce solution demonstrating geared adoption comfort market barriers diamond cgms marking first 1 event health burden 29 continuous free glucose shortcomings unsatisfactory prediction diabetes societal 2016 trial reduce completing leaders needle man cdm remove acceptance cornerstone 21st reimbursement events pivotal economic cgm 25b predictability ready monitoring hinder century self clinical reliability accelerate indigo severe obtaining poor opinion

Project "DiaMOND" data sheet

The following table provides information about the project.

Coordinator	INDIGO DIABETES Organization address address: BOLLEBERGEN 2B/30 city: GENT postcode: 9052 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Belgium [BE]
Project website	https://indigomed.com/diamond/
Total cost	3˙561˙818 €
EC max contribution	2˙493˙273 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-2
Funding Scheme	SME-2
Starting year	2018
Duration (year-month-day)	from 2018-07-01 to 2020-06-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	INDIGO DIABETES INDIGO DIABETES Organization address address: BOLLEBERGEN 2B/30 city: GENT postcode: 9052 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (GENT)	coordinator	2˙493˙273.00

Map

Project objective

Diabetes is the #1 health challenge of the 21st century. Continuous Glucose Monitoring or CGM ($1.25B market in 2016, growing 29%/yr) is today’s cornerstone of “diabetes self-management” and the most effective solution to reduce the economic and societal burden of diabetes. But the shortcomings of current CGMs hinder their wider adoption: high cost, unsatisfactory predictability of severe events, and poor user comfort. The DiaMOND project will remove these barriers by bringing needle-free, low-cost Continuous Diabetes Monitoring to market. DiaMOND is specifically geared at extending Indigo’s current CGM with reliable severe clinical event prediction and a great user experience; demonstrating the reliability in a first-in-man trial; creating market acceptance by involving Key Opinion Leaders; and obtaining reimbursement. Indigo will be ready for a large pivotal clinical study and CE marking after completing the DiaMOND project. DiaMOND will accelerate Indigo’s CDM market access by 2-3 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIAMOND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIAMOND" are provided by the European Opendata Portal: CORDIS opendata.